MDS

Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too.

The bonds that you make with your doctors can last a lifetime, and I’m so glad to call many of them a friend.

Reblozyl treatment in patients with anemia from lower-risk myelodysplastic syndromes achieved a greater independence from red blood cell transfusions compared with treatment with epoetin alfa.

Patients with lower risk myelodysplastic syndrome may now receive imetelstat — despite it not being FDA-approved.

I experienced unexpected rewards of decluttering.

Cancer taught me not to worry about the little things.

Sometimes I feel lazy and berate myself instead of admitting that I am ill.

Acute myeloid leukemia and myelodysplastic syndrome may affect nutritional status, and more work is needed to ensure that patients are getting the food intake that they need, researchers found.

Slowing down due to cancer and COVID-19 made me realize the parts of life I’ve been missing, though my new pace isn’t all bad.

As a cancer survivor, I feel that the song, "Here comes the sun" can inspire us all.

I’m happy to be alive and thankful for all that I have, but cancer and the COVID-19 pandemic has taken so much from me, physically, emotionally and financially.

My oncology team works together to take great care of myself and other patients.

A book I read made me realize the importance of positive thinking — even when going through cancer.

Muscle aches related to cancer treatment were having a major impact on my life.

My family is scattered throughout the country, so I often rely on friends to lend a helping hand.

Imetelstat improves eight- and 24-week transfusion independence in patients with low-risk myelodysplastic syndrome, according to topline study results.

As a cancer survivor, the COVID-19 pandemic continues to affect me and force me to miss activities — and people — I love.

One patient describes the management of symptoms of graft-versus-host disease as playing Whac-a-Mole and emphasizes the importance of awareness and education for both patients and their families.

While the large cancer hospitals do amazing work, I am extremely grateful for my local cancer center.

Despite cancer and the COVID-19 pandemic, my dog helps me find joy in the little things in life.

As a cancer survivor, I can relate to the lyrics of the Beatles’ song, “Let it Be.”

Cancer attacks your body and puts you in a very vulnerable position.

Of course, I want the best cancer care, but I realized that the beauty of the environment where I get it is important too.

From NFL Hall of Famer Shannon Sharpe and Monty Python member sharing their cancer diagnoses to “Good Morning America” promoting Be The Match, here’s what’s happening in the cancer space this week.

My new cancer treatment hardly has any side effects, making me wonder if researchers are focusing on making their drugs more tolerable for patients.

The last year was tough, but with a new cancer treatment center and other opportunities, I’m going to sit tight and bloom where planted.

The FDA’s decision allows patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndrome — types of blood cancer — to continue enrolling on the TakeAim Leukemia trial.

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

Cancer and COVID-19 took away my yearly “benchmarks” of time, when I fly out to see friends and family.

I must remember to be kind to myself, and not compare my current abilities to my pre-cancer days.